Literature DB >> 3275685

Detection of a potential progenitor cell in the human fetal pituitary that secretes both growth hormone and prolactin.

J J Mulchahey1, R B Jaffe.   

Abstract

The structural similarities between human PRL (hPRL) and human GH (hGH) suggest a common evolutionary origin of the two hormones. The existence of these similarities also suggests the existence of a developmental intermediate cell type which has the potential to produce and secrete both hPRL and hGH. We have applied reverse hemolytic plaque assays to monitor the secretions of individual fetal human pituitary cells to determine if any of these cells secrete both hPRL and hGH. When hPRL and hGH assays were performed sequentially on cells obtained from five fetuses of 18-22 weeks gestational age, we consistently found a subpopulation of cells that formed plaques in both assays, i.e. they secreted both hPRL and hGH. The majority of fetal cells secreting hPRL also secreted hGH at this stage of development. These data were corroborated with light and electron microscopic immunocytochemical localization of hPRL and hGH in a subpopulation of previously identified fetal somatotrophs. These findings suggest that in addition to the classical somatotrophs and lactotrophs, the fetal human pituitary contains an additional cell type which secretes both hPRL and hGH. The dual hormone-secreting cell may represent a common progenitor of these classical cell types. It also may be the cell of origin of those pituitary tumors that secrete both PRL and GH.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3275685     DOI: 10.1210/jcem-66-1-24

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Effect of 4 weeks of octreotide treatment on prolactin, thyroid stimulating hormone and thyroid hormones in acromegalic patients. A double blind placebo-controlled cross-over study.

Authors:  M Andersen; T B Hansen; J Bollerslev; P Bjerre; H D Schrøder; C Hagen
Journal:  J Endocrinol Invest       Date:  1995-12       Impact factor: 4.256

2.  Detection of growth hormone, prolactin and human beta-chorionic gonadotropin messenger RNA in growth-hormone-secreting pituitary adenomas by in situ hybridization.

Authors:  H Uhlig; W Saeger; S Fehr; D K Lüdecke
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

3.  Human growth hormone and prolactin secreting pituitary adenomas analyzed by in situ hybridization.

Authors:  R V Lloyd; M Cano; W F Chandler; A L Barkan; E Horvath; K Kovacs
Journal:  Am J Pathol       Date:  1989-03       Impact factor: 4.307

4.  Plurihormonality in pituitary adenomas associated with acromegaly.

Authors:  Fateme Salehi; Sandra Cohen; Luis V Syro; Humberto Uribe; Eva Horvath; Kalman Kovacs; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

Review 5.  Molecular pathogenesis of acromegaly.

Authors:  M R Drange; S Melmed
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

6.  Growth hormone (GH) and prolactin (PRL) gene expression and immunoreactivity in GH- and PRL-producing human pituitary adenomas.

Authors:  J Li; L Stefaneanu; K Kovacs; E Horvath; H S Smyth
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

7.  Use of a prolactin-Cre/ROSA-YFP transgenic mouse provides no evidence for lactotroph transdifferentiation after weaning, or increase in lactotroph/somatotroph proportion in lactation.

Authors:  Emma Castrique; Marta Fernandez-Fuente; Paul Le Tissier; Andy Herman; Andy Levy
Journal:  J Endocrinol       Date:  2010-02-05       Impact factor: 4.286

8.  Immunocytochemical study of the GH cells in the anterior pituitary gland of human fetus II. Anencephalic fetus.

Authors:  Toshiaki Tachibana; Takayasu Ito
Journal:  Hum Cell       Date:  2003-12       Impact factor: 4.174

9.  Colocalization of growth hormone (GH) and glycoprotein subunit alpha in GH-producing pituitary adenomas in acromegalic patients.

Authors:  S Furuhata; T Kameya; T Tsuruta; H Naritaka; S Toya
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

10.  Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study.

Authors:  Donato Iacovazzo; Richard Caswell; Benjamin Bunce; Sian Jose; Bo Yuan; Laura C Hernández-Ramírez; Sonal Kapur; Francisca Caimari; Jane Evanson; Francesco Ferraù; Mary N Dang; Plamena Gabrovska; Sarah J Larkin; Olaf Ansorge; Celia Rodd; Mary L Vance; Claudia Ramírez-Renteria; Moisés Mercado; Anthony P Goldstone; Michael Buchfelder; Christine P Burren; Alper Gurlek; Pinaki Dutta; Catherine S Choong; Timothy Cheetham; Giampaolo Trivellin; Constantine A Stratakis; Maria-Beatriz Lopes; Ashley B Grossman; Jacqueline Trouillas; James R Lupski; Sian Ellard; Julian R Sampson; Federico Roncaroli; Márta Korbonits
Journal:  Acta Neuropathol Commun       Date:  2016-06-01       Impact factor: 7.801

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.